ESC 365 - Heart failure prevalence and incidence in Germany: insights in ambulatory drug therapy and comorbidities

Open Access

Heart failure prevalence and incidence in Germany: insights in ambulatory drug therapy and comorbidities

Session: Novel risk factors and AI-enhanced prognostic strategies in heart failure

Topic: Epidemiology, Prognosis, Outcome

Speaker: Mr D. Jurczyk (Luebeck, DE)

Event: Heart Failure 2025

Congress Presentation

Add to my library

About the speaker

Mr Dominik Jurczyk

Schleswig-Holstein University Clinic, Lubeck Campus, Luebeck (Germany)

3 presentations

0 follower

5 more presentations in this session

Hypochloremia in chronic and acute heart failure scenarios: prevalence and risk factors

Speaker: Doctor P. Llacer (Madrid, ES)

Metformin associated lower risk of dementia among heart failure patients: a population-based retrospective cohort study

Speaker: Miss A. Matsumoto (HK)

Deep learning by vision transformer based assessment of image quality in echocardiography improves prediction of heart failure specific outcome

Speaker: Ms A. Romano Martinez (Mainz, DE)

Impact of coronavirus disease 19 (COVID-19) pandemic on age differences of heart failure with reduced ejection fraction (HFrEF) admissions and in-hospital outcomes

Speaker: Doctor A. Ceka (Tirana, AL)

Impact of recovery of vital signs after a 6-minute walk test over mortality in right heart failure patients.

Speaker: Doctor C. Chavez Guzman (Mexico City, MX)

Access the full session

Novel risk factors and AI-enhanced prognostic strategies in heart failure

Speakers: Mr D. Jurczyk, Doctor P. Llacer, Miss A. Matsumoto, Ms A. Romano Martinez, Doctor A. Ceka...

About the event

Heart Failure 2025

17 May - 20 May 2025

Sessions Presentations

Congress

ESC 365 is supported by

Explore sponsored resources

Explore sponsored resources

Explore sponsored resources